Australia markets closed

Evgen Pharma plc (8EV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.00050.0000 (0.00%)
At close: 09:50PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
838
442
0
194
Operating expenses
Research development
1,699
3,330
1,446
2,011
Selling general and administrative
565
765
564
635
Total operating expenses
5,145
5,512
3,191
3,398
Operating income or loss
-4,307
-5,070
-3,191
-3,204
Income before tax
-4,265
-5,006
-3,169
-3,213
Income tax expense
-912
-963
-439
-539
Income from continuing operations
-3,353
-4,043
-2,730
-2,674
Net income
-3,353
-4,043
-2,730
-2,674
Net income available to common shareholders
-3,353
-4,043
-2,730
-2,674
Basic EPS
-0.01
-0.01
-0.01
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.02
Basic average shares
274,888
274,888
274,888
149,199
Diluted average shares
274,888
274,888
274,888
149,199